SCHEMBL8046896

SCHEMBL8046896

CC(CO)C(O)CO.O=S(=O)(O)OS(=O)(=O)O

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.32
LMNA P02545 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8594552 0.84 TDP1 (0.33) TDP1LMNAL3MBTL1
E968 SCHEMBL31738448 0.84 LMNA (0.38) TDP1LMNAL3MBTL1
Propylene Glycol SCHEMBL28667172 0.81 TDP1 (0.53) TDP1
SCHEMBL7882754 0.78
SCHEMBL12264068 0.78
SCHEMBL2386043 0.78
SCHEMBL1988036 0.78
SCHEMBL13754785 0.78
E968 SCHEMBL29233654 0.77 PDE4A (0.38) TDP1LMNAL3MBTL1
SCHEMBL9651406 0.77 TSHR (0.36) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999045947-A9 IN VITRO FORMATION OF CONGOPHILIC MALTESE-CROSS AMYLOID PLAQUES TO IDENTIFY ANTI-PLAQUE THERAPEUTICS FOR THE TREATMENT OF ALZHEIMER'S AND PRION DISEASES UNIV WASHINGTON (US) 2000-03-02 WO claimed